Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors

Details for Australian Patent Application No. 2007215247 (hide)

Owner TransTech Pharma, Inc.

Inventors Subramanian, Govindan; Davis, Stephen; Mjalli, Adnan M. M.; Grella, Brian S.; Gopalaswamy, Ramesh; Guo, Xiaochuan; Arimilli, Murty N.; Zhu, Jeff; Andrews, Robert C.

Agent Spruson & Ferguson

Pub. Number AU-A-2007215247

PCT Pub. Number WO2007/095124

Priority 60/772,497 10.02.06 US; 60/791,187 11.04.06 US

Filing date 9 February 2007

Wipo publication date 23 August 2007

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4184 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

7 August 2008 PCT application entered the National Phase

  PCT publication WO2007/095124 Priority application(s): WO2007/095124

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007215249-Assays to predict atherosclerosis and dysfunctional high-density lipoprotein

2007215244-Radially extended support member for spinal nucleus implants and methods of use